ROBERT NELSEN Insider Trading $JUNO Juno Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ROBERT NELSEN.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ROBERT NELSEN. ROBERT NELSEN is in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Unity Biotechnology, Inc. ($UBX) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Juno Therapeutics, Inc. ($JUNO) and Director in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Sage Therapeutics, Inc. ($SAGE) and in Sienna Biopharmaceuticals, Inc. ($SNNA) and Director in Sienna Biopharmaceuticals, Inc. ($SNNA) and Director in Denali Therapeutics Inc. ($DNLI) and Director in Vir Biotechnology, Inc. ($VIR) and Director in Beam Therapeutics Inc. ($BEAM) and in Karuna Therapeutics, Inc. ($KRTX) and Director in Karuna Therapeutics, Inc. ($KRTX) and Director in Lyell Immunopharma, Inc. ($LYEL) and Director in Sana Biotechnology, Inc. ($SANA).

ROBERT NELSEN in Juno Therapeutics, Inc.

Trading Symbol: JUNO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT NELSEN: Director
Holdings: 3,234 shares
Current Value: $67,138
Latest Transaction: Mar 07 2018
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ROBERT NELSEN in Juno Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AGIO, BEAM, BLPH, DNLI, JUNO, KRTX, KYTH, LYEL, SAGE, SANA, SNNA, SYRS, UBX, VIR

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 07 2018	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Option Exercise	D	23.29	12,000	279,480	0
Mar 07 2018	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Option Exercise	D	42.40	12,000	508,800	0
Mar 07 2018	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Option Exercise	D	60.00	12,000	720,000	0
Mar 07 2018	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Sell	U	87.00	10,552,390	918,057,930	0	10.6 M to 0 (-100.00 %)
Mar 07 2018	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Sell	D	87.00	3,234	281,358	0	3.2 K to 0 (-100.00 %)
Mar 07 2018	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Sell	U	87.00	50,824	4,421,688	3,234	54.1 K to 3.2 K (-94.02 %)
Jan 09 2018	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Grant	A	0.00	237	0	54,058	53.8 K to 54.1 K (+0.44 %)
Oct 10 2017	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Grant	A	0.00	254	0	53,821	53.6 K to 53.8 K (+0.47 %)
Jul 07 2017	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Grant	A	0.00	400	0	53,567	53.2 K to 53.6 K (+0.75 %)
Jun 19 2017	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Option Exercise	A	23.29	12,000	279,480	12,000
Apr 06 2017	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Grant	A	0.00	573	0	53,167	52.6 K to 53.2 K (+1.09 %)
Jan 09 2017	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Grant	A	0.00	659	0	52,594	51.9 K to 52.6 K (+1.27 %)
Oct 17 2016	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Grant	A	0.00	447	0	51,935	51.5 K to 51.9 K (+0.87 %)
Jul 05 2016	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Grant	A	0.00	335	0	51,488	51.2 K to 51.5 K (+0.65 %)
Jun 21 2016	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Option Exercise	A	42.40	12,000	508,800	12,000
Apr 07 2016	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Grant	A	0.00	329	0	51,153	50.8 K to 51.2 K (+0.65 %)
Jun 16 2015	JUNO	Juno Therapeutics, ...	NELSEN ROBERT	Director	Option Exercise	A	60.00	12,000	720,000	12,000

Page: 1